Historically viewed as recession-proof, 2023 is expected to be a challenging year for the healthcare industry as macroeconomic factors – inflation, high labor expenses, volatile markets, supply chain snarls and other issues – exert their influence in ways not previously seen, according to McDermott Will & Emery’s Healthcare practice. In addition, healthcare providers – including hospitals and health systems – must grapple with the end of the COVID-19 public health emergency (PHE), which will require unwinding the multi-layered changes that were put into effect during the PHE. Read more.
Related Posts
Is M&A the Key to Survival for Hospitals and IDNs?
Definitive Healthcare looks at the implications of M&A on the healthcare industry, including how M&A could help hospitals and IDNs survive.
May 13, 2022
Pandemic Prompts Launch of New $75M US Telemedicine Fund From Swiftarc Ventures
The fund will focus on three initial areas: Obesity, Mental & Behavioral Health, and Pediatrics.
January 24, 2022
Record Number of Health-Care Deals Close 2021 with a Bang
December 2021 was jammed-packed with over 300 health-care industry transactions—the most active month of the year.
February 7, 2022
Frustration Over Surprise Billing Implementation Builds in House Hearing
Rep. Richard Neal, D-Mass., ranking minority member and the law’s author, called the implementation a “disappointment.”
September 21, 2023